Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$84,802,106
+$2,916,418 QoQ
Shares Held
333,906
-0.3% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#333
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRADLEY FOSTER & SARGENT INC/CT holds $254,262,538 across 12 Drug Manufacturers - General names. JNJ ranks #1 (33.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
333,906 | $84,802,106 | |
| 2 | ABBV |
AbbVie Inc.
|
219,509 | $55,237,244 | |
| 3 | LLY |
ELI LILLY & Co
|
35,186 | $42,203,147 | |
| 4 | MRK |
Merck & Co., Inc.
|
287,164 | $36,900,574 | |
| 5 | PFE |
Pfizer Inc
|
678,377 | $16,335,318 | |
| 6 | AMGN |
Amgen Inc
|
13,889 | $5,029,484 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
38,875 | $4,911,467 | |
| 8 | NVS |
Novartis AG
|
17,635 | $2,763,757 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,802,106 | 333,906 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $81,885,688 | 334,993 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $70,090,032 | 338,681 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $63,322,042 | 341,506 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $53,387,958 | 349,512 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $62,078,389 | 374,327 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $55,377,022 | 382,914 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $63,482,791 | 391,724 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $57,791,517 | 395,399 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $62,720,594 | 396,489 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $64,481,111 | 411,389 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $67,421,683 | 432,884 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $71,650,959 | 432,884 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $60,611,665 | 391,043 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $69,792,118 | 395,087 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $64,474,434 | 394,677 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $68,183,543 | 384,111 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $67,126,216 | 378,752 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $60,722,322 | 354,956 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $54,172,106 | 335,431 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $55,765,972 | 338,509 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $56,226,435 | 342,114 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $53,491,573 | 339,888 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $50,043,629 | 336,134 | Shares | Sole | 2020-10-26 | |
| 2020-03-31 | $42,977,726 | 327,749 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||